I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 19 studies | 29% ± 11% | |
| B cell | 14 studies | 22% ± 7% | |
| microglial cell | 11 studies | 28% ± 12% | |
| memory B cell | 9 studies | 17% ± 2% | |
| naive B cell | 8 studies | 17% ± 2% | |
| fibroblast | 8 studies | 23% ± 9% | |
| retinal rod cell | 7 studies | 30% ± 10% | |
| dendritic cell | 7 studies | 25% ± 10% | |
| natural killer cell | 6 studies | 17% ± 2% | |
| macrophage | 6 studies | 25% ± 9% | |
| endothelial cell of lymphatic vessel | 5 studies | 24% ± 6% | |
| astrocyte | 5 studies | 29% ± 8% | |
| epithelial cell | 4 studies | 27% ± 7% | |
| mast cell | 4 studies | 21% ± 7% | |
| retinal bipolar neuron | 4 studies | 23% ± 5% | |
| retina horizontal cell | 4 studies | 23% ± 8% | |
| endothelial cell of vascular tree | 4 studies | 26% ± 15% | |
| GABAergic neuron | 4 studies | 28% ± 13% | |
| pericyte | 4 studies | 20% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 16% ± 1% | |
| CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| glomerular endothelial cell | 3 studies | 17% ± 0% | |
| myeloid cell | 3 studies | 16% ± 1% | |
| plasma cell | 3 studies | 29% ± 4% | |
| adipocyte | 3 studies | 20% ± 4% | |
| mononuclear phagocyte | 3 studies | 17% ± 1% | |
| lymphocyte | 3 studies | 21% ± 4% | |
| ON-bipolar cell | 3 studies | 25% ± 11% | |
| rod bipolar cell | 3 studies | 54% ± 11% | |
| germinal center B cell | 3 studies | 25% ± 4% | |
| glutamatergic neuron | 3 studies | 46% ± 17% | |
| oligodendrocyte precursor cell | 3 studies | 27% ± 5% | |
| connective tissue cell | 3 studies | 18% ± 2% | |
| smooth muscle cell | 3 studies | 18% ± 1% | |
| melanocyte | 3 studies | 52% ± 26% | |
| transit amplifying cell | 3 studies | 33% ± 21% | |
| interneuron | 3 studies | 29% ± 9% |
